GATSL1 activators are a class of compounds specifically designed to enhance the activity of the GATSL1 protein, which is thought to play a role in various cellular processes, including gene expression regulation and signal transduction pathways. The development of these activators begins with a comprehensive understanding of the GATSL1 protein's structure, function, and the mechanisms by which it interacts with other cellular components. High-throughput screening (HTS) is a critical initial step in this process, enabling researchers to rapidly evaluate a vast array of compounds to identify those that can increase the activity of GATSL1. This screening aims to pinpoint molecules that can either directly bind to and enhance the function of GATSL1 or modulate the protein's activity indirectly by affecting its interaction with other proteins or DNA. Once potential activators are identified, structure-activity relationship (SAR) studies are conducted to refine these compounds, improving their efficacy and specificity. SAR studies involve the systematic modification of the compounds' chemical structures and assessing how these changes influence their ability to activate GATSL1. Through this iterative process, the chemical properties of the activators are optimized to maximize their beneficial effects on GATSL1 activity.
The optimization of GATSL1 activators also involves advanced analytical techniques, such as X-ray crystallography and nuclear magnetic resonance (NMR) spectroscopy, to gain detailed insights into the interactions between the activators and the GATSL1 protein. These structural analyses are crucial for understanding the molecular basis of activation, revealing how the activators bind to GATSL1 and induce conformational changes that enhance its activity. Additionally, cellular assays are employed to verify the activators' efficacy within a biological context, ensuring that they can effectively enhance GATSL1 function in living cells. These assays help to confirm that the observed increase in GATSL1 activity leads to the desired cellular outcomes, such as altered gene expression patterns or changes in signaling pathway activation. Through these comprehensive approaches, combining chemical synthesis, structural analysis, and biological validation, GATSL1 activators are developed with a focus on precisely modulating the function of GATSL1. This targeted modulation offers valuable insights into GATSL1's role in cellular physiology and provides tools for further exploration of its biological functions.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
L-Arginine | 74-79-3 | sc-391657B sc-391657 sc-391657A sc-391657C sc-391657D | 5 g 25 g 100 g 500 g 1 kg | $20.00 $31.00 $61.00 $219.00 $352.00 | 2 | |
Directly providing arginine could influence the activity of CASTOR2 by altering intracellular arginine levels, thereby potentially affecting mTORC1 signaling. | ||||||
L-Leucine | 61-90-5 | sc-364173 sc-364173A | 25 g 100 g | $21.00 $62.00 | ||
An essential amino acid known to activate mTORC1, which could indirectly influence the CASTOR2-mTORC1 signaling axis. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Stimulates mTORC1 activity via the PI3K/AKT pathway, potentially influencing the CASTOR2-mTORC1 interaction. | ||||||
D(+)Glucose, Anhydrous | 50-99-7 | sc-211203 sc-211203B sc-211203A | 250 g 5 kg 1 kg | $38.00 $198.00 $65.00 | 5 | |
High glucose levels can activate mTORC1, thereby potentially influencing CASTOR2's interaction with mTORC1. | ||||||
Spermidine | 124-20-9 | sc-215900 sc-215900B sc-215900A | 1 g 25 g 5 g | $57.00 $607.00 $176.00 | ||
Known to inhibit mTORC1, could be used to study the effects on CASTOR2 regulation of mTORC1. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Affects various signaling pathways and could have indirect effects on mTORC1 and CASTOR2. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Known to influence mTORC1 signaling, could indirectly affect the CASTOR2-mTORC1 interaction. | ||||||
1,1-Dimethylbiguanide, Hydrochloride | 1115-70-4 | sc-202000F sc-202000A sc-202000B sc-202000C sc-202000D sc-202000E sc-202000 | 10 mg 5 g 10 g 50 g 100 g 250 g 1 g | $20.00 $43.00 $63.00 $156.00 $260.00 $510.00 $31.00 | 37 | |
Commonly used to lower blood glucose levels; has been shown to affect mTORC1 signaling, potentially impacting CASTOR2. | ||||||